A Critical Role for Immune System Response in Mediating Anti-influenza Drug Synergies Assessed by Mechanistic Modeling-Reference-Cited by-同舟云学术

A Critical Role for Immune System Response in Mediating Anti-influenza Drug Synergies Assessed by Mechanistic Modeling

Published:2014-09 Issue:9 Volume:3 Page:135
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT: Pharmacometrics & Systems Pharmacology

Author:

Li Z¹,Zhou H¹,Lu Y¹,Colatsky T¹

Affiliation:

1. Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences; Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring Maryland USA

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/psp.2014.32/fullpdf

Reference49 articles.

1. Dynamics of influenza virus infection and pathology;Saenz;J. Virol.,2010

2. The impact of influenza epidemics on mortality: introducing a severity index;Simonsen;Am. J. Public Health,1997

3. Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells;Chizhmakov;J. Physiol.,1996

4. Controlling influenza by inhibiting the virus's neuraminidase;Garman;Curr. Drug Targets,2004

5. Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A;Reuman;Antiviral Res.,1989

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calibration and Validation of a Mechanistic COVID‐19 Model for Translational Quantitative Systems Pharmacology – A Proof‐of‐Concept Model Development for Remdesivir;Clinical Pharmacology & Therapeutics;2022-06-29

2. The induction of virus-neutralizing antibodies in influenza A-infected mice treated with Oseltamivir phosphate: effect of dosage and scheduling;Acta virologica;2022

3. Genetic basis and identification of candidate genes for salt tolerance in rice by GWAS;Scientific Reports;2020-06-19

4. Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment;Frontiers in Physiology;2017-08-23

5. Improving the In Silico Assessment of Proarrhythmia Risk by Combining hERG (Human Ether-à-go-go-Related Gene) Channel–Drug Binding Kinetics and Multichannel Pharmacology;Circulation: Arrhythmia and Electrophysiology;2017-02